EMA Authorised: Ambirix (hepatitis A virus (inactivated);hepatitis B surface antigen) — GlaxoSmithKline Biologicals S.A.

View source ↗

Summary

Ambirix, a vaccine containing inactivated hepatitis A virus and hepatitis B surface antigen, has been authorised for immunization against hepatitis A and B.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• Ambirix

Snippet

Status: Authorised. Therapeutic area: Hepatitis B;Hepatitis A;Immunization. MAH: GlaxoSmithKline Biologicals S.A.. Decision date: 29/07/2026